| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |